Impact BioMedical (IBO) shares fell 8% in recent Monday trading after the company made its debut on the NYSE American Market.
The stock was trading at $2.75 in recent trading, below the IPO price of $3.
Impact BioMedical said earlier in the day it priced the IPO of 1.5 million common shares at $3 per share.
The company said it granted the underwriters a 45-day option to buy an additional 225,000 shares.
The offering is expected to close on Tuesday, the company added.
Price: 2.75, Change: -0.25, Percent Change: -8.33
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.